Observing kidney diseases related to the immune system

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on patients with immunologically-mediated kidney diseases such as nephrotic syndrome, glomerulonephritis, and lupus nephritis. Participants will undergo thorough evaluations, including history, physical examinations, and laboratory tests, to better understand the causes and characteristics of these conditions. Blood and urine samples will be collected for further immunological research, aiming to identify potential biomarkers and improve treatment responses. The study will also explore the natural history and complications associated with these diseases.

Why it matters

Who can join: the full rules

* INCLUSION CRITERIA:

In order to be eligible to participate in this study, a participant must meet all of the following criteria:

1. Adults \>= 18 years of age and children 10-17 years of age
2. Participants with

   1. known, proven, or suspected immunologically-mediated kidney diseases, including but not limited to nephrotic syndrome, glomerulonephritis, membranous nephropathy, lupus nephritis, and nephritis associated with other systemic or connective tissue disorders, OR
   2. immunologically-mediated diseases with the potential for kidney disease.
3. Ability of the participant or guardian to understand and the willingness of the participant or guardian to provide written informed consent.

EXCLUSION CRITERIA:

An individual who meets any of the following criteria will be excluded from participation in this study:

1. Concomitant medical problems which would confound the interpretation of studies of the immunologic kidney disorder.
2. Concomitant medical, surgical, or other conditions for which inadequate facilities or funds are available to support their care at the NIH.

Where it's running

• National Institutes of Health Clinical Center
  Bethesda, Maryland, United States Recruiting

Study contacts

• Principal investigator: Meryl A Waldman, M.D. — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Study coordinator: Meryl A Waldman, M.D.
• Email: waldmanm@mail.nih.gov
• Phone: (301) 451-6990

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pedal Pump Device for Lower Extremity Edema in Hospitalized Patients

  This study tests a foot-pump device to see if it is tolerable and can help reduce swelling in the legs of hospitalized patients with edema.

  Recruiting Hillcrest · Tulsa, Oklahoma · NCT07760363

• Adapting and testing PEN-Plus in Zambian primary care

  Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.

  Recruiting Centre for Infectious Disease Research in Zambia · Lusaka, Lusaka Province · NCT07753681

• Effects of general vs spinal-epidural anesthesia on kidney transplant biomarkers

  This study tests whether sevoflurane general anesthesia or combined spinal-epidural anesthesia changes markers of cellular stress and protective peptides in adults undergoing kidney transplantation.

  Recruiting University of Gaziantep · Gaziantep, State/Province · NCT07678073

• Impact of a Clinical Information System on hospital outcomes for adults with chronic diseases

  This study tests whether implementing a Clinical Information System helps reduce readmissions or death within 30 days after hospital discharge for adults with chronic conditions in Alberta.

  Recruiting University of Calgary · Calgary, Alberta · NCT07609381

• GSK4771261 in Healthy Adults Aged 25–55 in Asia and Europe

  This study tests whether GSK4771261 is safe and how it behaves in the body of healthy adults to see if it could be used safely in the future.

  Recruiting Phase 1 GlaxoSmithKline · Groningen · NCT07600450

• Red propolis supplementation for people with chronic kidney disease

  This study tests whether taking red propolis daily for 8 weeks can reduce inflammation and oxidative stress in people with chronic kidney disease who are managed without dialysis.

  Recruiting Universidade Federal Fluminense · Rio de Janeiro, Rio de Janeiro · NCT07597005

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.